Indeed, treatment with salicylate induced the expression of pri-miR-34a, mature miR-34a, and pri-miR-34b/c in three CRC cell lines with wildtype p53 and also in three p53 mutant CRC cell lines (Fig. 3A–C). The gene discussed is TP53; the disease is colorectal carcinoma.